0000950170-23-058900.txt : 20231103
0000950170-23-058900.hdr.sgml : 20231103
20231103170406
ACCESSION NUMBER: 0000950170-23-058900
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hopkins Janet Jill
CENTRAL INDEX KEY: 0001997710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 231377220
MAIL ADDRESS:
STREET 1: C/O AURA BIOSCIENCES, INC.
STREET 2: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
4
1
ownership.xml
4
X0508
4
2023-11-01
0001501796
Aura Biosciences, Inc.
AURA
0001997710
Hopkins Janet Jill
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
false
true
false
false
Chief Medical Officer
false
Common Stock
2023-11-01
4
A
false
135000
0
A
135000
D
Stock Option (Right to Buy)
8.97
2023-11-01
4
A
false
200000
0
A
2033-10-31
Common Stock
200000
200000
D
These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Company's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Company's common stock. These RSUs vest in four substantially equal annual installments beginning on November 15, 2024, subject to the Reporting Person's continued service as of each such vesting date.
The shares underlying this option vest as follows: 25% of the shares vest on October 16, 2024 with the remainder vesting thereafter in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
/s/ Julie Feder, Attorney-in-fact
2023-11-03